Flurazepam Hydrochloride Capsule shortage
Flurazepam Hydrochloride Capsule is currently listed in shortage by the FDA. The FDA lists 6 affected products. The reported reason: Regulatory delay. This page was last refreshed from FDA data on Oct 4, 2026.
Flurazepam capsules are in shortage, with one of two makers currently unable to supply them due to manufacturing delays at their production facility. The other maker still lists supply available in both the 15 mg and 30 mg strengths.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Flurazepam Hydrochloride Capsule. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 15, 2026Currently in shortage6 of 6 products affected.
-
Sep 1, 2026FDA refreshed this shortage record2 products updated.
-
Aug 3, 2022First reported to the FDA6 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Chartwell Molecular Holdings LLC 📞 845-268-5000 Ext. 510 4 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) | — | Available | — | — |
| Current | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) | — | Available | — | — |
| Current | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) | — | Available | — | — |
| Current | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) | — | Available | — | — |
Manufacturer: Rising Pharma Holdings, Inc. 📞 1-844-874-7464 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01) | — | Unavailable | Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility. | Regulatory delay |
| Current | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01) | — | Unavailable | Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility. | Regulatory delay |
These rows are manufacturer reports to the FDA for Flurazepam Hydrochloride Capsule — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Flurazepam Hydrochloride Capsule? options further down this page.
Why is Flurazepam Hydrochloride Capsule in shortage?
For flurazepam hydrochloride capsules, the shortage specifically affects Rising Pharma Holdings. Their 15 mg and 30 mg capsules are both currently unavailable because of hold-ups at the outside factory they use to manufacture the product. Regulators have flagged issues at that contract facility, and Rising Pharma doesn't expect to have their supply back until the fourth quarter of 2026 — so roughly the last three months of that year.
It's worth knowing that this report only covers Rising Pharma's products. Chartwell Molecular Holdings also makes both the 15 mg and 30 mg flurazepam capsules, and their products are listed as available in this same FDA report.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Flurazepam Hydrochloride Capsule, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Flurazepam Hydrochloride Capsule?
Flurazepam hydrochloride capsules are currently on the FDA drug-shortage list. If you take this medicine for sleep, please know that supply is still available for both strengths through at least one manufacturer, so there is a good chance your pharmacy can obtain what you need.
Both the 15 mg and 30 mg capsules remain available from one maker (Chartwell Molecular Holdings). A second manufacturer, Rising Pharma, has reported both strengths as unavailable, with supply expected to return around Q4 2026. The reported reasons are a regulatory delay and manufacturing delays at a contract facility. In short, one of two manufacturers is affected — this does not mean the medicine is gone everywhere.
Here is what I suggest:
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy to order your strength; both 15 mg and 30 mg still have an available source, and pharmacies can check wholesalers and other manufacturers.
- If your pharmacy cannot locate your exact strength, ask your prescriber or pharmacist about options, such as a different strength to make up your dose.
- Manufacturer contact numbers are listed on this page for reference, though your pharmacy usually handles those calls.
This information comes from national, manufacturer-reported FDA data and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
- This is a controlled substance. Transfers between pharmacies and switching strengths have extra federal/state rules — ask the pharmacy before you assume a transfer is possible.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Therapeutic equivalents & pricing 3 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Flurazepam Hydrochloride 15 mg | Chartwell | 90 capsules | — | AB | FDA listed |
| Flurazepam Hydrochloride 30 mg | Chartwell | 90 capsules | — | AB | FDA listed |
| Flurazepam Hydrochloride 15 mg | Chartwell | 30 capsules | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Flurazepam Hydrochloride Capsule — that fall in the same broad treatment class (sedative-hypnotics - benzodiazepines) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Flurazepam Hydrochloride Capsule shortage FAQs
Is Flurazepam Hydrochloride Capsule in shortage?
Why is Flurazepam Hydrochloride Capsule in shortage?
Which products are affected?
When will Flurazepam Hydrochloride Capsule be available again?
What should I do if I take Flurazepam Hydrochloride Capsule?
Still have a question about the Flurazepam Hydrochloride Capsule shortage?
Ask a pharmacist about this shortage →View Flurazepam Hydrochloride Capsule on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.